<DOC>
	<DOCNO>NCT00091676</DOCNO>
	<brief_summary>The primary objective Phase 3 study definitively confirm safety efficacy BiovaxId , autologous tumor derive immunoglobulin idiotype vaccine , measure significant prolongation period disease free survival administer patient indolent follicular Non-Hodgkin 's Lymphoma ( NHL ) first complete remission .</brief_summary>
	<brief_title>Study BiovaxId Tumor Derived Idiotype Vaccine Patients With Follicular Lymphoma</brief_title>
	<detailed_description>Patients Stage III-IV follicular lymphoma tumor &gt; 2cm ( Stage II allow tumor &gt; 5cm ) , previously untreated local radiation , provide tumor material tissue biopsy production patient-specific Ig idiotype vaccine conjugate immunogenic protein KLH . After complete PACE CHOP-R chemotherapy achieve complete remission , follow wait period reconstitute immune system , patient remain remission randomize active treatment arm receive series 5 idiotype vaccination accompany immune stimulant GM-CSF . Patients randomize control arm receive time-matched series KLH injection also accompany GM-CSF . Patients subsequently study observe immune response non-specific immune stimulating agent specific immune response vaccine . Patients follow minimum 4 year post-randomization relapse .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Immunoglobulin Idiotypes</mesh_term>
	<criteria>Inclusion/ Diagnosis indolent follicular lymphoma ( follicular smallcleaved cell , follicular mixed follicular large cell centrocytes ) surface IgM IgG phenotype . Stage IIIIV lymph node &gt; 2cm Stage II lymph node &gt; 5 cm No prior chemotherapy local radiation ( great 2 site ) ECOG &lt; 2 Survival &gt; 1 yr Serum creatinine &lt; 1.5 mg/dl Bilirubin &lt; 1.5 mg/dl SGOT/SGPT &lt; 3.5 ULN No HIV antibodies HBV antigen Negative pregnancy screen ( female ) No unrelated neoplasm previous 10 year No evidence primary secondary CNS lymphoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>follicular</keyword>
	<keyword>lymphoma</keyword>
	<keyword>Non-Hodgkins</keyword>
	<keyword>idiotype</keyword>
	<keyword>vaccine</keyword>
	<keyword>indolent follicular Non-Hodgkins Lymphoma</keyword>
	<keyword>tumor-derived</keyword>
	<keyword>B-cell</keyword>
	<keyword>cancer</keyword>
</DOC>